324 related articles for article (PubMed ID: 20309545)
41. Kaposiform hemangioendothelioma of the bone in children and adolescents.
Kuo C; Warren M; Malvar J; Miller JM; Shah R; Navid F; Luu M; Anselmo DM; Mascarenhas L
Pediatr Blood Cancer; 2022 Jan; 69(1):e29392. PubMed ID: 34606171
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
43. Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.
Rodriguez V; Lee A; Witman PM; Anderson PA
J Pediatr Hematol Oncol; 2009 Jul; 31(7):522-6. PubMed ID: 19564750
[TBL] [Abstract][Full Text] [Related]
44. Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences.
Ji Y; Chen S; Peng S; Xia C; Li L
Orphanet J Rare Dis; 2019 Jul; 14(1):165. PubMed ID: 31277673
[TBL] [Abstract][Full Text] [Related]
45. Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study.
Zhang G; Chen H; Gao Y; Liu Y; Wang J; Liu XY
Br J Dermatol; 2018 May; 178(5):1213-1214. PubMed ID: 29388191
[No Abstract] [Full Text] [Related]
46. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma.
Croteau SE; Gupta D
Semin Cutan Med Surg; 2016 Sep; 35(3):147-52. PubMed ID: 27607323
[TBL] [Abstract][Full Text] [Related]
47. Giant retroperitoneal Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: A case report.
Wu D; Xu J; Wang P; Zhou S
Asian J Surg; 2023 Feb; 46(2):1014-1015. PubMed ID: 35961905
[No Abstract] [Full Text] [Related]
48. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
Wang Z; Li K; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2014 Aug; 61(8):1518-9. PubMed ID: 24482015
[No Abstract] [Full Text] [Related]
49. Identical Presentation of Scapular Osteolysis in Two Patients with Thoracic Kaposiform Hemangioendothelioma.
Alonso Arroyo V; Lopez-Gutierrez JC; Martinez R; Fernandez-Pineda I
Pediatr Dermatol; 2017 May; 34(3):e146-e149. PubMed ID: 28382716
[TBL] [Abstract][Full Text] [Related]
50. Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery.
Jiang RS; Hu R
Int J Clin Oncol; 2012 Oct; 17(5):512-6. PubMed ID: 21947597
[TBL] [Abstract][Full Text] [Related]
51. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
Chan S; Cassarino DS
JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816
[No Abstract] [Full Text] [Related]
52. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
Wang H; Guo X; Duan Y; Zheng B; Gao Y
Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
[TBL] [Abstract][Full Text] [Related]
53. Kaposiform hemangioendothelioma without cutaneous involvement.
Ji Y; Chen S; Li L; Yang K; Xia C; Li L; Yang G; Kong F; Lu G; Liu X
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2475-2484. PubMed ID: 30293120
[TBL] [Abstract][Full Text] [Related]
54. Anesthestic management of Kassabach-Meritt Phenomenon in an adult: case report.
Elkoundi A; Samali M; Kartite N; Tbouda M; Bensghir M; Haimeur C
BMC Anesthesiol; 2016 Nov; 16(1):109. PubMed ID: 27829366
[TBL] [Abstract][Full Text] [Related]
55. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.
Gruman A; Liang MG; Mulliken JB; Fishman SJ; Burrows PE; Kozakewich HP; Blei F; Frieden IJ
J Am Acad Dermatol; 2005 Apr; 52(4):616-22. PubMed ID: 15793511
[TBL] [Abstract][Full Text] [Related]
56. Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!
Vetter-Kauczok CS; Ströbel P; Bröcker EB; Becker JC
Vasc Health Risk Manag; 2008; 4(1):263-6. PubMed ID: 18629354
[TBL] [Abstract][Full Text] [Related]
57. Kaposiform haemangioendothelioma in a nine-year-old boy with Kasabach-Merritt phenomenon.
Zhang G; Gao Y; Liu X
Br J Haematol; 2017 Oct; 179(1):9. PubMed ID: 28714059
[No Abstract] [Full Text] [Related]
58. Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis.
Sobrino-Fernández E; Campos-Domínguez M; Gregorio-Hernández R; Huerta-Aragonés J; Beléndez-Bieler C; Lancharro-Zapata Á; Franco-Fernández ML; Bernardo-Atienza B; Sánchez-Luna M
Pediatr Dermatol; 2017 May; 34(3):e128-e129. PubMed ID: 28318049
[TBL] [Abstract][Full Text] [Related]
59. A case of sirolimus treatment of kaposiform hemangioendothelioma in the neck.
Kuwabara Y; Ozeki M; Hira K; Fujisaki H; Ohnishi H
Pediatr Int; 2022 Jan; 64(1):e15000. PubMed ID: 35289458
[No Abstract] [Full Text] [Related]
60. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
